Clinical Trials Logo

IBS - Irritable Bowel Syndrome clinical trials

View clinical trials related to IBS - Irritable Bowel Syndrome.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06117865 Not yet recruiting - Clinical trials for IBS - Irritable Bowel Syndrome

Digital Treatment of Irritabel Bowel Syndrome (IBS)

DIGIBS
Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The aim of this work is to identify whether the digital treatment program Mage-tarmskolen has an effect on patients with IBS. Our secondary objectives is to address multiple aspects of digital treamtent success of the different modules. The patients will be randomized to one of four arms and will be delivered different kinds of digital treatment. All patients will have access to ask questions to a registred dietitian. Primary end point is the proportion of patients with treatment success in the low FODMAP, behavioral therapy or both groups, versus the patient education group (sham). Treatment effect is defines as an improvement of 50 points or more on the IBS severity scoring system at 3 months agter treatment start compared to the score beofre treatment.

NCT ID: NCT06066866 Not yet recruiting - Healthy Clinical Trials

Microbiome Sampling in GI Disease With a Focus on Small Intestinal Microbial Assessment

Start date: January 1, 2024
Phase:
Study type: Observational

GI disorders are influenced by the gut microbiome. To date, sampling of the small intestine in GI disorders has been limited. The investigators plan to sample the small intestinal contents during endoscopy for research purposes.

NCT ID: NCT05480059 Not yet recruiting - Clinical trials for IBS - Irritable Bowel Syndrome

Assessment of Psychological Symptoms and Health Related Quality of Life in Patients With Irritable Bowel Syndrome

Start date: August 1, 2022
Phase:
Study type: Observational

To evaluate the relation between the clinical presentations and the psychiatric co-morbidities with the quality of life in patients with irritable bowel syndrome.